Trading Signals: BAX Stock Price Prediction and Forecast (Mon. Dec. 1, 2014 - Wed. Sep. 27, 2023)(Baxter International Inc.)
| BAX latest price $44.7400 (-0.22%) ($44.2300 - $45.1150) on Tue. Jan. 17, 2023. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.37% (three month average) | RSI | 29 | Latest Price | $44.7400(-0.22%) | Stocks Behave Similarly | Similar Stock List | Weekly Trend | BAX declines -5.9% a week on average for past two weeks. | Market Behavior | Value stocks sell-off for large cap. Normal for small cap. | Correlated ETFs | Broad market will support BAX advance at 0% a week (0% probability) XLV(40%) IWD(36%) SDY(35%) SPLV(35%) VYM(33%) | Factors Impacting BAX price | BAX will decline at least -1.185% in a week (0% probabilities). VIXM(-22%) VXX(-11%) GLD(-10%) MCHI(-9%) KWEB(-8%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.185% (StdDev 2.37%) | Hourly BBV | -0.2 () | Intraday Trend | -0.6% | | | |
|
1 - 5 Day Possible Target | $35.76(-20.07%) | Resistance Level | $48.92 | 5 Day Moving Average | $45.17(-0.95%) | 10 Day Moving Average | $47.32(-5.45%) | 20 Day Moving Average | $48.92(-8.54%) | To recent high | -22.4% | To recent low | 0.1% | Market Cap | $22.826b | | | | Baxter International, Inc. provides portfolio of essential renal and hospital products, including acute and chronic dialysis, sterile IV solutions, infusion systems and devices, parenteral nutrition therapies; premixed and oncolytic injectable, bio surgery products and anesthetics, drug reconstitution systems; and pharmacy automation, software and services. It operates through the following segment: Americas, Europe, Middle East & Africa and Asia-Pacific. The company was founded by Davis Baxter in 1931 and is headquartered in Deerfield, IL. |